ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

New Breast Cancer Trials to Include Pre Vs. Post Operative Chemotherapy, CSF Pilot Studies

August 5, 1988

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982

In Brief: NIEHS to Observe20th Anniversary Dec. 3-5 With Scientific Presentations, Big Celebration

November 21, 1986

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

January 15, 1999

Hormone Therapy Can Reduce Survival In Men With Heart Problems

August 26, 2011